✨
AI Summary
- Arrowhead Pharmaceuticals' Javier San Martin compares RNAi and CRISPR gene silencing technologies.
- He outlines the roadmap and pipeline strategy for RNAi-based medicines.
- The discussion covers developing treatments for intractable diseases by targeting specific genes.
Guests on This Episode
JM
Javier San Martin
1 podcast appearance